Dynamics in 18-fluoromisonidazole PET/CT and perfusion-weighted 3-Tesla MRI parameters as biomarkers for predicting treatment outcome in HNSCC. (December 2016) - Bunea, H.; Bunea, A.; Wiedenmann, N.; Stoykow, C.; Mix, M.; Majerus, L.; Ludwig, U.; Rischke, H.C.; Langer, M.; Meyer, P.T.; Bock, M.; Grosu, A.L.